Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

FFA's causes may include environmental triggers and genetic factors.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The document suggests a bacteria plays a significant role in acne rosacea and that white hair can regain color after transplant, meriting more research on reversing grey hair.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Using scalp stem cells can improve hair transplants.

MPA increases cancer spread by boosting Eph A2 activity.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Folliculitis decalvans was successfully treated with doxycycline and ozenoxacin.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.